Standard BioTools Supports XDENT LAB's NADL Membership for Global Dental Collaboration
- XDENT LAB joins NADL as a Supplier Member, emphasizing its commitment to quality and collaboration with U.S. dental labs.
- The company operates FDA-registered, ISO-certified facilities, producing a range of high-quality dental products.
- XDENT LAB aims to enhance global dental industry standards, promoting excellence and collaboration through its NADL membership.
XDENT LAB Joins NADL, Strengthening Global Dental Collaboration
XDENT LAB, a Vietnam-based dental laboratory established in 2017, marks a significant milestone by officially joining the National Association of Dental Laboratories (NADL) as a Supplier Member on October 10, 2025. This membership underscores XDENT LAB's dedication to quality and collaboration with U.S. dental laboratories, enhancing its standing within the international dental community. CEO Alex Tran articulates that this step not only validates the company's commitment to high standards and ethical practices but also reinforces its mission to serve as a reliable partner for U.S.-based dental labs. By producing high-quality restorations crafted by skilled Vietnamese technicians, XDENT LAB aims to bridge the gap between cost-effective manufacturing and superior craftsmanship.
Operating two FDA-registered and ISO 13485-certified facilities, XDENT LAB employs over 100 technicians who specialize in a wide array of dental products, including removable dentures, implant prosthetics, and zirconia restorations. The company's stringent adherence to international standards positions it as a valuable outsourcing partner for dental laboratories in the U.S., Australia, and Israel. By focusing on full-service manufacturing solutions, XDENT LAB enables its partners to reduce operational costs while maintaining the quality of their offerings. This strategic focus on quality assurance and compliance is essential as dental labs increasingly seek reliable suppliers that can deliver consistent results.
Through its membership in the NADL, XDENT LAB is poised to further its contributions to the dental industry. The company aligns itself with the association’s goals of promoting excellence, transparency, and education within dental laboratory practices. This partnership not only enhances XDENT LAB's credibility as a global supplier but also allows it to engage in dialogue with industry leaders, share best practices, and stay updated on evolving regulations and standards. XDENT LAB’s long-term vision emphasizes its commitment to being "proudly made in Vietnam to trusted worldwide," which reflects its ambition to expand its footprint in the global dental market.
In related developments, XDENT LAB's entry into the NADL signifies a growing trend of international collaboration in the dental industry. As dental laboratories increasingly seek partnerships that ensure quality and efficiency, XDENT LAB's capabilities position it well to meet these demands. The company's expansion into new markets is crucial as the global dental landscape continues to evolve.
As XDENT LAB strengthens its global presence, it sets a precedent for other dental laboratories worldwide, showcasing the importance of quality, compliance, and collaboration in delivering exceptional dental restorations. The company's commitment to these values will likely foster greater trust and reliability among its partners, ultimately benefiting patients and dental professionals alike.
Related Cashu News

Bristol-Myers Squibb's Reclassification Enhances Growth Potential in Defensive Investment Strategy
Bristol-Myers Squibb Company (Ticker: BMY) undergoes a key reclassification across the Russell indexes, marking a transformative moment for the company. Moving to the Russell 1000 Defensive and Russel…

Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Vertex Pharmaceuticals (Ticker: VRTX) receives a significant boost in its ongoing battle against sickle cell disease with the recent FDA approval of an expanded label for its gene therapy product, Cas…

Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Gilead Sciences (Ticker: GILD) makes significant strides in oncology therapy with the recent approval of its drug Trodelvy for patients with unresectable or metastatic triple-negative breast cancer. T…

Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Merck & Co. (Ticker: MRK) has recently made significant strides in the pharmaceutical landscape, particularly with its advancements in HIV treatment. The company's innovative drug, IDVYNSO, has receiv…

